Study to assess effect of Ayurvedic drugs on Recurrent Allergic conjunctivitis

A Randomized Controlled Trial To assess The Efficacy Of Shigru Pallava Madhu Saindhava Aschyotana and Vasakadi Granules in Kaphaja Abhishyand With Special reference to Vernal Keratoconjuctivitis

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/07/055497

Enrollment

Registered

2023-07-21

Start date

Unknown

Completion date

Unknown

Last updated

2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H102- Other acute conjunctivitis

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: • Patients presenting with signs and symptoms of Kaphaja Abhishyanda described as per Ayurvedic texts and Vernal Keratoconjunctivitis diagnosed by â??Japanese Guideline for allergic conjunctival disease. • Age from 5-25 years

Exclusion criteria

Exclusion criteria: Patients affected by other allergic ocular disease such as Atopic KeratoConjuctivitis,Giant Papillary Conjunctivitis and Seasonal Allergic Conjunctivitis. • Patients under eye drop or systemic treatments for other disease. • Cases complicated with corneal pannus ,corneal neovascularization ,corneal ulcer, keratoconus and corneal plaques . • Contact lens wearers. • Patients suffering from other systemic disorders.

Design outcomes

Primary

Measure	Time frame
To assess and compare the efficacy of topical and systemic Ayurvedic drugs in the patients with VKCTimepoint: 12 weeks	—

Secondary

Measure	Time frame
To assess the safety & ocular tolerance of shigru madhu saindhava ashchyotana in patients with VKCTimepoint: 8 weeks	—

Countries

India

Contacts

Public ContactKomal

National Institute of ayurveda deemed to be university jorawar singh gate amer road jaipur

shalakya007@gmail.com9461065960

Outcome results